Lu Yang

2.8k citations

98 papers · 2.0k · h-index 24

Impact in

Cancer Research top 2%
- Cancer Genomics and Diagnostics
Oncology top 2%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers

Papers in

Oncology 59
- Lung Cancer Research Studies 26
- Colorectal Cancer Treatments and Studies 14
- Cancer Immunotherapy and Biomarkers 12
- CAR-T cell therapy research 5
Pulmonary and Respiratory Medicine 53
- Lung Cancer Treatments and Mutations 46
- Lung Cancer Diagnosis and Treatment 8

Co-authors: Hua Bai (15 shared papers)Jie Wang (11 shared papers)Yan Wang (25 shared papers)Jun Zhao (7 shared papers)Tongtong An (15 shared papers)Haiyan Xu (23 shared papers)Yuyan Wang (12 shared papers)Minglei Zhuo (11 shared papers)
Journals: Cancer Medicine (6 papers)Journal of Clinical Oncology (6 papers)Lung Cancer (5 papers)Frontiers in Oncology (3 papers)Journal of Thoracic Oncology (2 papers)
Partner nations: China United States Ethiopia

In The Last Decade

Lu Yang

88 papers receiving 2.0k citations

Peers

Countries citing papers authored by Lu Yang

Since Specialization

Citations

This map shows the geographic impact of Lu Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Yang more than expected).

Fields of papers citing papers by Lu Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Yang. The network helps show where Lu Yang may publish in the future.

Co-authors

The 25 scholars most cited alongside Lu Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lu Yang Line = papers co-authored together Lu Yang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 98 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Epidermal Growth Factor Receptor Mutations in Plasma DNA Samples Predict Tumor Response in Chinese Patients With Stages IIIB to IV Non–Small-Cell Lung Cancer Journal of Clinical Oncology ·Hua Bai, Li Mao, hang Shu Wang, Jun Zhao, Lu Yang, T. An, Xin Wang, chun Jian Duan, Na Wu, Zhi Qing Guo, yi Xu Liu, Hong Ning Liu, ye Yu Wang, Jie Wang	2009	232
2	Influence of Chemotherapy on EGFR Mutation Status Among Patients With Non–Small-Cell Lung Cancer Journal of Clinical Oncology ·Hua Bai, Zhijie Wang, Ke‐Neng Chen, Jun Zhao, J. Jack Lee, Shuhang Wang, Qinghua Zhou, Minglei Zhuo, Li Mao, Tongtong An, Jianchun Duan, Lu Yang, Meina Wu, Zhen Liang, Yuyan Wang, Xiaozheng Kang, Jie Wang	2012	165
3	Inhibition of keratinocyte ferroptosis suppresses psoriatic inflammation Cell Death and Disease ·Yanhong Shou, Lu Yang, Yongsheng Yang, Jinhua Xu	2021	142
4	KRAS ‐G12D mutation drives immune suppression and the primary resistance of anti‐PD‐1/PD‐L1 immunotherapy in non‐small cell lung cancer Cancer Communications ·Chengming Liu, Sufei Zheng, Zhanyu Wang, Sihui Wang, Xin‐Feng Wang, Lu Yang, Haiyan Xu, Zheng Cao, Xiaoli Feng, Qi Xue, Yan Wang, Nan Sun, Jie He	2022	99
5	Detection and Clinical Significance of Intratumoral EGFR Mutational Heterogeneity in Chinese Patients with Advanced Non-Small Cell Lung Cancer PLoS ONE ·Hua Bai, Zhijie Wang, Yuyan Wang, Minglei Zhuo, Qinghua Zhou, Jianchun Duan, Lu Yang, Meina Wu, Tongtong An, Jun Zhao, Jie Wang	2013	83
6	Potential Clinical Significance of a Plasma-Based KRAS Mutation Analysis in Patients with Advanced Non–Small Cell Lung Cancer Clinical Cancer Research ·Shuhang Wang, Tongtong An, Jie Wang, Jun Zhao, Zhijie Wang, Minglei Zhuo, Hua Bai, Lu Yang, Yan Zhang, Xin Wang, Jianchun Duan, Yuyan Wang, Qingzhi Guo, Meina Wu	2010	83
7	EGFR exon 20 insertion mutations in Chinese advanced non-small cell lung cancer patients: Molecular heterogeneity and treatment outcome from nationwide real-world study Lung Cancer ·Guangjian Yang, Jun Li, Haiyan Xu, Yaning Yang, Lu Yang, Fei Xu, Bing Xia, Viola W. Zhu, Misako Nagasaka, Yan Yang, LI Ya-pin, Weini Qiu, Jianming Ying, Sai‐Hong Ignatius Ou, Yan Wang	2020	75
8	Mesenchymal stromal cells as vehicles of tetravalent bispecific Tandab (CD3/CD19) for the treatment of B cell lymphoma combined with IDO pathway inhibitor d-1-methyl-tryptophan Journal of Hematology & Oncology ·Xiaolong Zhang, Yuanyuan Yang, Leisheng Zhang, Lu Yang, Qing Zhang, Dongmei Fan, Yizhi Zhang, Yanjun Zhang, Ye Zhou, Dongsheng Xiong	2017	59
9	Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancer BMC Medicine ·Chengming Liu, Lu Yang, Haiyan Xu, Sufei Zheng, Zhanyu Wang, Sihui Wang, Yaning Yang, Shuyang Zhang, Xiaoli Feng, Nan Sun, Yan Wang, Jie He	2022	55
10	EGFR mutations are associated with prognosis but not with the response to front-line chemotherapy in the Chinese patients with advanced non-small cell lung cancer Lung Cancer ·Meina Wu, Jun Zhao, Sonya Wei Song, Minglei Zhuo, Xin Wang, Hua Bai, Shuhang Wang, Lu Yang, Tongtong An, Yan Zhang, Jianchun Duan, Yuyan Wang, Qingzhi Guo, Xuyi Liu, Ninghong Liu, Jie Wang	2009	47
11	RBCK1 promotes p53 degradation via ubiquitination in renal cell carcinoma Cell Death and Disease ·Sifan Yu, Jie Dai, Meng Ma, Tianxiao Xu, Yan Kong, Chuanliang Cui, Zhihong Chi, Lu Si, Huan Tang, Lu Yang, Xinan Sheng, Jun Guo	2019	43
12	DNA Methylation status of Wnt antagonist SFRP5 can predict the response to the EGFR-tyrosine kinase inhibitor therapy in non-small cell lung cancer Journal of Experimental & Clinical Cancer Research ·Jian Zhu, Yuyan Wang, Jianchun Duan, Hua Bai, Zhijie Wang, Lai Wei, Jun Zhao, Minglei Zhuo, Shuhang Wang, Lu Yang, Tongtong An, Meina Wu, Jie Wang	2012	42
13	Inhibition of phosphoglycerate kinase 1 attenuates autoimmune myocarditis by reprogramming CD4+ T cell metabolism Cardiovascular Research ·Lu Yang, Ning Zhao, Yuwei Wu, Shuaitao Yang, Qiongfeng Wu, Qian Dong, Yimei Du	2023	42
14	Prognostic significance of PLIN1 expression in human breast cancer Oncotarget ·Cefan Zhou, Ming Wang, Li Zhou, Yi Zhang, Weiyong Liu, Wenying Qin, Rong He, Lu Yang, Yefu Wang, Xing‐Zhen Chen, Jingfeng Tang	2016	40
15	Serum Detection of Epidermal Growth Factor Receptor Gene Mutations Using Mutant-Enriched Sequencing in Chinese Patients with Advanced Non-Small Cell Lung Cancer Journal of International Medical Research ·Beibei Jiang, Feng Liu, Lu Yang, Wenjie Zhang, Haihua Yuan, Jun Wang, Gang Huang	2011	40
16	EML4-ALK Rearrangement and Its Clinical Significance in Chinese Patients with Advanced Non-Small Cell Lung Cancer Oncology ·Zhijie Wang, Xu‐Chao Zhang, Hua Bai, Jun Zhao, Minglei Zhuo, Tongtong An, Jianchun Duan, Lu Yang, Meina Wu, Shuhang Wang, Yuyan Wang, Yi‐Long Wu, Jie Wang	2012	39
17	SGLT2 inhibitor, canagliflozin, ameliorates cardiac inflammation in experimental autoimmune myocarditis International Immunopharmacology ·Qi Long, Lixia Li, Hongmin Yang, Lu Yang, Han Yang, Yaoxi Zhu, Yaohan Tang, Changhu Liu, Jing Yuan	2022	37
18	Osimertinib for Chinese advanced non-small cell lung cancer patients harboring diverse EGFR exon 20 insertion mutations Lung Cancer ·Guangjian Yang, Jun Li, Haiyan Xu, Yang Sun, Liu Liu, Hong‐Shuai Li, Lu Yang, Yuan Zhang, Guohui Li, Yan Wang	2020	36
19	The detection of EGFR mutation status in plasma is reproducible and can dynamically predict the efficacy of EGFR‐TKI Thoracic Cancer ·Zhen Huang, Zhijie Wang, Hua Bai, Meina Wu, Tongtong An, Jun Zhao, Lu Yang, Jianchun Duan, Minglei Zhuo, Yuyan Wang, Shuhang Wang, Jie Wang	2012	36
20	Tobacco carcinogen induces tryptophan metabolism and immune suppression via induction of indoleamine 2,3-dioxygenase 1 Signal Transduction and Targeted Therapy ·Fan Liang, Guizhen Wang, Yan Wang, Yaning Yang, Zhesheng Wen, Dongni Chen, Wenfeng Fang, Bin Zhang, Lu Yang, Chen Zhang, Si-Chong Han, Fuying Yang, Di Wang, Lijun Liang, Zheng Wang, Yong Zhao, Changli Wang, Li Zhang, Guang‐Biao Zhou	2022	35

About Lu Yang

Lu Yang is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Surgery, having authored 98 papers that have together received 2.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (46 papers), Lung Cancer Research Studies (26 papers), Colorectal Cancer Treatments and Studies (14 papers), Cancer Genomics and Diagnostics (13 papers), Cancer Immunotherapy and Biomarkers (12 papers), Lung Cancer Diagnosis and Treatment (8 papers), Cancer therapeutics and mechanisms (5 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Cancer Research (704 citations), Oncology (1.0k citations), Pulmonary and Respiratory Medicine (1.2k citations), Immunology (215 citations) and Molecular Biology (627 citations). Lu Yang has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Hua Bai, Jie Wang, Yan Wang, Jun Zhao, Tongtong An, Haiyan Xu, Yuyan Wang, Minglei Zhuo, Jinhua Xu and Yanhong Shou. Their work appears in journals such as Cancer Medicine, Journal of Clinical Oncology, Lung Cancer, Frontiers in Oncology and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Lu Yang

Impact in

Papers in i

In The Last Decade

Lu Yang

Peers

Countries citing papers authored by Lu Yang

Fields of papers citing papers by Lu Yang

All Works

About Lu Yang

Explore authors with similar magnitude of impact

Papers in